# q01 rev 3 - blind solver A (fresh blind-solver, packet solver-1), 2026-10-06

Raw return as received:

answer: Flat. When Cencora closed the divestiture in April 2026, its fiscal 2026 guidance (set February 4, 2026) called for flat adjusted operating income, meaning about 0% growth, in "Other". Other was the reporting category that then held U.S. Consulting Services. The fiscal 2025 base was $352M.

confidence: high

path:
1. **The unit was in Other in fiscal 2026.**
   - D06 (Nov 5, 2025), line 121: "Beginning in the first quarter of fiscal 2026, the Company's reporting structure will be comprised of U.S. Healthcare Solutions, International Healthcare Solutions, and Other… Other, which is not considered a reportable segment, will consist of… MWI Animal Health, Profarma, U.S. Consulting Services and the other components of PharmaLex."
   - D01 line 81 and D03 line 86 say the same thing: these businesses are "grouped together in Other… U.S. Consulting Services".
2. **The closing was in April 2026.**
   - D05 (Aug 5, 2026), line 81: "U.S. Consulting Services (which was divested in April 2026)".
   - D05 line 95: "the April 2026 divestiture of U.S. Consulting Services". Footnote line 269 repeats this.
   - D01 line 47 shows the unit was still "classified as held for sale" in Q1.
3. **How the Other adjusted operating income guidance changed:**
   - D06 (Nov 5, 2025), line 138: "|Other(1)|1% to 4% decline|$352M|"
   - D01 (Feb 4, 2026), line 114: "|Other(2)|Flat|$352M|". Line 103 explains the change: "improved results in Other as certain depreciable assets have been fully impaired as of December 31, 2025."
   - D03 (May 6, 2026), line 123: "|Other(2)|High-single digit growth|$352M|". Line 112 gives the reason: "updated operating income expectations in Other as a result of MWI now being accounted for as 'held for sale'".
   - D05 (Aug 5, 2026), line 118: "|Other(2)|~10% growth|$352M|"
4. **Which guidance applied at the closing.** April 2026 falls after February 4 and before May 6, so the February 4 guidance (D01) was in force. D03 line 17 says EPS guidance was "raised from the previous range of $17.45 to $17.75", which is exactly D01's range. That supports there being no update in between.
5. **Row check.** D01 has two "Other(2)" rows. The one under "Adjusted operating income" reads "Flat" against $352M. The other is the revenue row, "1% to 5% growth" against $8.2B. Flat growth implies roughly $352M of fiscal 2026 adjusted operating income for Other.
6. **Source check.** The docs/ originals match the extracted text: D01 docs line 115 reads "Flat", and D03 docs line 124 reads "High-single digit growth".

minimal_documents: D01 and D05.
- D01 gives the "Flat" figure and shows Other contained the unit.
- D05 is the only document that dates the closing to April 2026. D03 does not mention the closing, so nothing in the packet can replace D05.
- D03 backs up the timing: its "previous range" matches D01, and it carries the first update after the closing. D06 is optional; it shows the reorganization and the original "1% to 4% decline".

readings:
- **First guidance issued after the closing** (D03, May 6, 2026): "High-single digit growth". It came after the April closing and was driven by MWI's held-for-sale status, so it is not the guidance in effect at the closing.
- **The unit's pre-fiscal-2026 home.** D06 says U.S. Healthcare Solutions was redefined to exclude "legacy U.S. Consulting Services", which implies the unit sat there before. D01 guides that segment to "14% to 16% growth". This reading is weak because the unit was in Other at the closing.
- **Original fiscal 2026 guidance** (D06): "1% to 4% decline". It was replaced on February 4, before the closing.
- **Latest guidance** (D05): "~10% growth". It came after the closing.

gaps:
- No exact closing day is given, only "April 2026". Any April date gives the same answer.
- The packet may not hold every guidance update. D05 says the previous EPS range was "$17.70 to $17.90", but D03 set "$17.65 to $17.90". So at least one update after May 6 is missing from the packet. That does not affect the February–May window, where D03's previous range matches D01.
- Bold formatting, which the releases use to mark updated metrics, is lost in both text/ and docs/. It does not change the "Flat" value.
- Not read in full: D02 and D04 (fiscal 2025 releases; searched only), and the reconciliation and supplemental sections of D01, D03, D05 and D06. The long lines that matched "flat" in those sections were "inflationary" hits, and the consulting searches found no other mentions.
- question.txt was not read.

contaminated: no

Relevant files:
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r3-v2-32031947d3dbdf85273e6007a056f3d7f3cc0e882e1d3c3f61c3417e759e0eeb\solver-1\text\D01.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r3-v2-32031947d3dbdf85273e6007a056f3d7f3cc0e882e1d3c3f61c3417e759e0eeb\solver-1\text\D03.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r3-v2-32031947d3dbdf85273e6007a056f3d7f3cc0e882e1d3c3f61c3417e759e0eeb\solver-1\text\D05.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r3-v2-32031947d3dbdf85273e6007a056f3d7f3cc0e882e1d3c3f61c3417e759e0eeb\solver-1\text\D06.txt
